Web www.bestsyndication.com
Match.com


 

Subscribe to our news

Enter your email address:


Add to Google
Add to My AOL  


Health

FDA announces Product Safety Recall for MOTRIN Infant Drops

| | |
FDA announces Product Safety Recall for MOTRIN Infant Drops

Best Syndication News - The U.S. Food and Drug Administration announced that McNeil Consumer Healthcare has voluntarily recalled certain lots of Concentrated MOTRIN Infants’ Drops Original Berry Flavor. About 200,000 bottles are involved in the recall, but only three lots of the ½ fluid ounce bottles are involved.

The recall was announced when the company discovered 1 mm sized plastic particles in a different product lot that was being manufactured and has not been shipped. McNeil believes that the plastic pieces came from a third party supplier of ibuprofen, which is an ingredient used to make their product. Out of extreme safety measures, McNeil Consumer Healthcare has decided to recall three lots of Concentrated MOTRIN Infants’ Drops Original Berry Flavor ½ fluid ounce sized bottles, because these lots also used the same batch of ibuprofen.

Share/Save/Bookmark
       Post to Facebook

Atrial Fibrillation combined with Chronic Kidney Disease increase risk for ESRD

| | |
Stethoscope - BSN

(Best Syndication New) - Researchers from the University of California, San Francisco (UCSF) and the Kaiser Permanente Northern California Division of Research, found an increased risk for kidney failure in people who have atrial fibrillation and chronic kidney disease. In general, kidney function can fail over time with the chronic condition which can lead to dialysis treatments or a kidney transplant. Kidney problems are more likely to worsen in atrial fibrillation patients who already have kidney function impairment. The study results were published in the journal Circulation.

Irregular heart rhythm is a very common type of atrial fibrillation. Patients who have atrial fibrillation along with chronic kidney disease or end stage-renal disease (ESRD) are at an increased risk for suffering from a stroke or death. The researchers wanted to understand why atrial fibrillation patients with kidney disease are more likely to have end-stage renal disease compared to those with chronic kidney disease only.

Share/Save/Bookmark
       Post to Facebook

Consuming Less Added Sugar reduces Body Weight Slightly

| | | | |
credit: National Cancer Institute Renee Comet (Photographer) - PD

(Best Syndication News) - Reducing sugar intake may slightly lower body weight, according to a new study,. The researchers found sugar intake reductions helped reduce body weight by an average of 1.76 pounds. The study results were published online at bmj.com.

Previous research suggested that an excessive intake of sugar is related to obesity. One common finding: people who drank sugar-sweetened beverages were at an increased risk for becoming obese. However, the authors noted that some studies could not establish a significant link between sugared beverages and obesity.

Share/Save/Bookmark
       Post to Facebook

Drinking Sweet Beverages associated with Increased Depression Risk

| | | |
Credit: National Cancer Institute Renee Comet (Photographer) - PD

(Best Syndication News) - Researchers found that people who drank sweetened beverages had an increased risk for depression. The risk was especially elevated with those who drank diet drinks. However, people who drank coffee had a slightly reduced risk for depression. The study results will be shared at the American Academy of Neurology’s 65th Annual Meeting in San Diego, which is scheduled to be held March 16-23, 2013.

The study author, Honglei Chen, MD, PhD, a member of the American Academy of Neurology, along with the National Institutes of Health in Research Triangle Park in North Carolina, explained that drinking sweetened beverages versus coffee and tea might affect mental health in addition to physical health.

Share/Save/Bookmark
       Post to Facebook

FDA suggests reduced dose for Zolpidem Sleeping Medications

| | |
Medicine bottle - BSN

(Best Syndication News) - The U.S. Food and Drug Administration (FDA) expressed concern for consumers who take certain medications containing zolpidem to treat insomnia. The medication could cause the user to be less capable at completing activities that require full attention, such as driving a vehicle.

Because of this concern, the FDA has notified the manufacturers of the sleep drugs containing zolpidem to lower the recommended dose. Zolpidem is marketed as a generic or under the brand names of Ambien (oral tablet), Edluar (tablet placed under the tongue), and Zolpimist (oral spray). Additionally, the FDA is currently trying to determine the risk of next-morning impairment in other sleep drugs and OTC products.

Share/Save/Bookmark
       Post to Facebook
Syndicate content


Important: The material on Best Syndication is for informational purposes only and is not meant to be advice. Authors may have or will receive monetary compensation from the company's product/s mentioned. You should always seek professional advice before making any legal, financial or medical decisions and this website cannot substitute or replace any trained professional consultation. Use of this site means that you agree to our TERMS OF SERVICE


Advertise On This Site

Copyright © 2006-2014 By Best Syndication All Rights Reserved

Enter your email address:

Subscribe to our

Local News